Micro Therapeutics
This article was originally published in The Gray Sheet
Executive Summary
Initiates a 40-patient European clinical trial at six centers for the EMBOLYX liquid embolic system for the treatment of arteriovenous malformations. To date, three patients have been treated, each with an AVM located in the area of the brain associated with motor skills. The company anticipates completing the trial by year-end, with a European product launch planned for the first half of 1999